# I-Corps: The utility of a mining byproduct, thorium, and a novel radium separation technique to provide full value chain radioisotope supply for Ra224, Ac225, and Pb212 oncology drugs

> **NIH NIH R43** · RADTRAN LLC · 2022 · $55,000


## Key facts

- **NIH application ID:** 10561296
- **Project number:** 3R43CA261365-01A1S1
- **Recipient organization:** RADTRAN LLC
- **Principal Investigator:** Saleem Drera
- **Activity code:** R43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $55,000
- **Award type:** 3
- **Project period:** 2021-09-22 → 2022-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10561296

## Citation

> US National Institutes of Health, RePORTER application 10561296, I-Corps: The utility of a mining byproduct, thorium, and a novel radium separation technique to provide full value chain radioisotope supply for Ra224, Ac225, and Pb212 oncology drugs (3R43CA261365-01A1S1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10561296. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*